Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie
Go back to Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie| AbbVie (NYSE: ABBV) | Delayed: 234.76 +4.75 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $230.01 | 52 Week High | $68.12 | |||
| Open | $232.97 | 52 Week Low | $50.71 | |||
| Day High | $235.31 | P/E | 50.92 | |||
| Day Low | $231.30 | EPS | $4.61 | |||
| Volume | 7,493,121 | |||||
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 69.62 +0.63 (0.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.99 | 52 Week High | $18.39 | |||
| Open | $69.38 | 52 Week Low | $6.96 | |||
| Day High | $70.21 | P/E | N/A | |||
| Day Low | $68.93 | EPS | $-0.58 | |||
| Volume | 2,716,069 | |||||
